PIGU
Basic information
Region (hg38): 20:34560542-34698790
Previous symbols: [ "CDC91L1" ]
Links
Phenotypes
GenCC
Source:
- glycosylphosphatidylinositol biosynthesis defect 21 (Strong), mode of inheritance: AR
- glycosylphosphatidylinositol biosynthesis defect 21 (Moderate), mode of inheritance: AR
- glycosylphosphatidylinositol biosynthesis defect 21 (Strong), mode of inheritance: AR
- glycosylphosphatidylinositol biosynthesis defect 21 (Limited), mode of inheritance: AD
- glycosylphosphatidylinositol biosynthesis defect 21 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 31353022 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (95 variants)
- Glycosylphosphatidylinositol_biosynthesis_defect_21 (10 variants)
- PIGU-related_disorder (7 variants)
- Inborn_genetic_diseases (7 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PIGU gene is commonly pathogenic or not. These statistics are base on transcript: NM_000080476.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 31 | 35 | ||||
| missense | 38 | 44 | ||||
| nonsense | 1 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 2 | 1 | 43 | 34 | 2 |
Highest pathogenic variant AF is 0.000013010685
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PIGU | protein_coding | protein_coding | ENST00000217446 | 12 | 116565 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0000190 | 0.975 | 125722 | 0 | 26 | 125748 | 0.000103 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.721 | 208 | 239 | 0.869 | 0.0000126 | 2838 |
| Missense in Polyphen | 73 | 91.345 | 0.79917 | 1180 | ||
| Synonymous | -0.546 | 104 | 97.2 | 1.07 | 0.00000558 | 857 |
| Loss of Function | 2.03 | 11 | 21.1 | 0.522 | 8.92e-7 | 268 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000324 | 0.000324 |
| Ashkenazi Jewish | 0.000497 | 0.000496 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.0000464 | 0.0000462 |
| European (Non-Finnish) | 0.0000270 | 0.0000264 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.000132 | 0.000131 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the GPI transamidase complex. May be involved in the recognition of either the GPI attachment signal or the lipid portion of GPI. {ECO:0000269|PubMed:12802054}.;
- Pathway
- Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human);Attachment of GPI anchor to uPAR;Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- 0.145
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.73
Haploinsufficiency Scores
- pHI
- 0.178
- hipred
- Y
- hipred_score
- 0.530
- ghis
- 0.609
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.634
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pigu
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- pigu
- Affected structure
- Rohon-Beard neuron
- Phenotype tag
- abnormal
- Phenotype quality
- increased age
Gene ontology
- Biological process
- GPI anchor biosynthetic process;attachment of GPI anchor to protein;protein localization to cell surface;regulation of JAK-STAT cascade
- Cellular component
- endoplasmic reticulum membrane;plasma membrane;membrane;integral component of endoplasmic reticulum membrane;GPI-anchor transamidase complex
- Molecular function
- GPI-anchor transamidase activity;GPI anchor binding